Double GLP-1, GIP

Tirz is a synthetic peptide that functions as a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. By engaging both incretin pathways, it has become a key research tool for studying glucose homeostasis, appetite regulation, and energy balance.

In preclinical and clinical studies, Tirz has been shown to enhance insulin secretion in a glucose-dependent manner, improve insulin sensitivity, and reduce body weight through combined effects on satiety and metabolism. Researchers often use it to investigate how dual incretin signaling influences lipid handling, glycemic control, and adiposity reduction, providing insights beyond what single-pathway GLP-1 receptor agonists offer.

All products are intended for in vitro or laboratory research use only. This compound is not intended for therapeutic or diagnostic purposes and has not been approved by the FDA for human or veterinary use.

** This product is in lyophilized powder form and requires reconstitution solution (BAC Water) for research.